141 related articles for article (PubMed ID: 20594126)
21. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease.
Shioya M; Nishida A; Yagi Y; Ogawa A; Tsujikawa T; Kim-Mitsuyama S; Takayanagi A; Shimizu N; Fujiyama Y; Andoh A
Clin Exp Immunol; 2007 Sep; 149(3):480-6. PubMed ID: 17590175
[TBL] [Abstract][Full Text] [Related]
22. Immunopathogenesis of inflammatory bowel disease: current concepts.
Bamias G; Cominelli F
Curr Opin Gastroenterol; 2007 Jul; 23(4):365-9. PubMed ID: 17545770
[TBL] [Abstract][Full Text] [Related]
23. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
[TBL] [Abstract][Full Text] [Related]
24. Allium sativum (garlic) suppresses leukocyte inflammatory cytokine production in vitro: potential therapeutic use in the treatment of inflammatory bowel disease.
Hodge G; Hodge S; Han P
Cytometry; 2002 Aug; 48(4):209-15. PubMed ID: 12210145
[TBL] [Abstract][Full Text] [Related]
25. Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease.
Peterson RL; Wang L; Albert L; Keith JC; Dorner AJ
Lab Invest; 1998 Dec; 78(12):1503-12. PubMed ID: 9881950
[TBL] [Abstract][Full Text] [Related]
26. CD4 T-cell differentiation and inflammatory bowel disease.
Zenewicz LA; Antov A; Flavell RA
Trends Mol Med; 2009 May; 15(5):199-207. PubMed ID: 19362058
[TBL] [Abstract][Full Text] [Related]
27. IL-28A is a key regulator of T-cell-mediated liver injury via the T-box transcription factor T-bet.
Siebler J; Wirtz S; Weigmann B; Atreya I; Schmitt E; Kreft A; Galle PR; Neurath MF
Gastroenterology; 2007 Jan; 132(1):358-71. PubMed ID: 17241885
[TBL] [Abstract][Full Text] [Related]
28. Genetic and spontaneous models of inflammatory bowel disease in rodents: evidence for abnormalities in mucosal immune regulation.
Powrie F; Leach MW
Ther Immunol; 1995 Apr; 2(2):115-23. PubMed ID: 8729882
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses.
Minty A; Chalon P; Derocq JM; Dumont X; Guillemot JC; Kaghad M; Labit C; Leplatois P; Liauzun P; Miloux B
Nature; 1993 Mar; 362(6417):248-50. PubMed ID: 8096327
[TBL] [Abstract][Full Text] [Related]
30. Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency.
Mannon PJ; Fuss IJ; Dill S; Friend J; Groden C; Hornung R; Yang Z; Yi C; Quezado M; Brown M; Strober W
Gastroenterology; 2006 Sep; 131(3):748-56. PubMed ID: 16952544
[TBL] [Abstract][Full Text] [Related]
31. Immune mechanisms in chronic inflammatory bowel disease.
Braegger CP; MacDonald TT
Ann Allergy; 1994 Feb; 72(2):135-41. PubMed ID: 8109803
[TBL] [Abstract][Full Text] [Related]
32. [Inflammatory bowel diseases: an immunological approach].
Sepúlveda SE; Beltrán CJ; Peralta A; Rivas P; Rojas N; Figueroa C; Quera R; Hermoso MA
Rev Med Chil; 2008 Mar; 136(3):367-75. PubMed ID: 18575665
[TBL] [Abstract][Full Text] [Related]
33. IL-23 promotes tumour incidence and growth.
Langowski JL; Zhang X; Wu L; Mattson JD; Chen T; Smith K; Basham B; McClanahan T; Kastelein RA; Oft M
Nature; 2006 Jul; 442(7101):461-5. PubMed ID: 16688182
[TBL] [Abstract][Full Text] [Related]
34. IL-21: roles in immunopathology and cancer therapy.
Søndergaard H; Skak K
Tissue Antigens; 2009 Dec; 74(6):467-79. PubMed ID: 19845910
[TBL] [Abstract][Full Text] [Related]
35. Tumor necrosis factor family members and inflammatory bowel disease.
Wang J; Fu YX
Immunol Rev; 2005 Apr; 204():144-55. PubMed ID: 15790356
[TBL] [Abstract][Full Text] [Related]
36. IL-12 and IL-23: master regulators of innate and adaptive immunity.
Langrish CL; McKenzie BS; Wilson NJ; de Waal Malefyt R; Kastelein RA; Cua DJ
Immunol Rev; 2004 Dec; 202():96-105. PubMed ID: 15546388
[TBL] [Abstract][Full Text] [Related]
37. Role of regulatory T cells in gastrointestinal inflammatory disease.
van Driel IR; Ang DK
J Gastroenterol Hepatol; 2008 Feb; 23(2):171-7. PubMed ID: 18289352
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses.
Parrish-Novak J; Foster DC; Holly RD; Clegg CH
J Leukoc Biol; 2002 Nov; 72(5):856-63. PubMed ID: 12429707
[TBL] [Abstract][Full Text] [Related]
39. Regulatory T cells reinforce intestinal homeostasis.
Barnes MJ; Powrie F
Immunity; 2009 Sep; 31(3):401-11. PubMed ID: 19766083
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease.
Benahmed M; Meresse B; Arnulf B; Barbe U; Mention JJ; Verkarre V; Allez M; Cellier C; Hermine O; Cerf-Bensussan N
Gastroenterology; 2007 Mar; 132(3):994-1008. PubMed ID: 17324400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
